VOYA Investment Management
NVCR icon

VOYA Investment Management’s NovoCure NVCR Stock Holding History

VOYA Investment Management’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$198K Sell
18,165
-449
-2% -$5.61K ﹤0.01% 2119
2025
Q4 		$241K Hold
18,614
– – ﹤0.01% 2075
2025
Q3 		$240K Sell
18,614
-9,786
-34% -$131K ﹤0.01% 2106
2025
Q2 		$506K Sell
28,400
-370
-1% -$6.45K ﹤0.01% 1892
2025
Q1 		$513K Sell
28,770
-29,568
-51% -$672K ﹤0.01% 1863
2024
Q4 		$1.74M Buy
58,338
+5,476
+10% +$116K ﹤0.01% 1358
2024
Q3 		$826K Sell
52,862
-20,068
-28% -$364K ﹤0.01% 1743
2024
Q2 		$1.25M Sell
72,930
-12,976
-15% -$228K ﹤0.01% 1508
2024
Q1 		$1.34M Sell
85,906
-73,979
-46% -$1.09M ﹤0.01% 1506
2023
Q4 		$2.39M Buy
159,885
+78,357
+96% +$1.05M ﹤0.01% 1306
2023
Q3 		$1.32M Sell
81,528
-306,791
-79% -$8.85M ﹤0.01% 1499
2023
Q2 		$16.1M Buy
388,319
+106,758
+38% +$6.63M 0.02% 582
2023
Q1 		$16.9M Sell
281,561
-38,774
-12% -$3.1M 0.02% 577
2022
Q4 		$23.5M Buy
320,335
+25,399
+9% +$1.91M 0.03% 498
2022
Q3 		$22.4M Buy
294,936
+41,352
+16% +$3.23M 0.03% 465
2022
Q2 		$17.6M Sell
253,584
-12,748
-5% -$960K 0.04% 351
2022
Q1 		$22.1M Sell
266,332
-7,072
-3% -$521K 0.05% 330
2021
Q4 		$20.5M Sell
273,404
-168,033
-38% -$16.9M 0.04% 364
2021
Q3 		$51.3M Buy
441,437
+135,596
+44% +$20.5M 0.1% 185
2021
Q2 		$67.8M Sell
305,841
-204,315
-40% -$39.7M 0.13% 163
2021
Q1 		$67.4M Buy
510,156
+124,391
+32% +$19.7M 0.14% 155
2020
Q4 		$66.8M Sell
385,765
-157,047
-29% -$21.5M 0.14% 155
2020
Q3 		$60.4M Sell
542,812
-241,788
-31% -$19.3M 0.13% 160
2020
Q2 		$46.5M Buy
784,600
+607,605
+343% +$40M 0.11% 187
2020
Q1 		$11.9M Sell
176,995
-132,342
-43% -$10.5M 0.03% 429
2019
Q4 		$26.1M Sell
309,337
-56,200
-15% -$4.54M 0.05% 303
2019
Q3 		$27.3M Buy
365,537
+332,111
+994% +$26.6M 0.06% 297
2019
Q2 		$2.11M Buy
33,426
+3,576
+12% +$181K ﹤0.01% 1033
2019
Q1 		$1.44M Sell
29,850
-517
-2% -$24.9K ﹤0.01% 1185
2018
Q4 		$1.02M Buy
30,367
+2,108
+7% +$77.1K ﹤0.01% 1308
2018
Q3 		$1.48M Buy
28,259
+329
+1% +$13.1K ﹤0.01% 1206
2018
Q2 		$874K Buy
27,930
+1,814
+7% +$50.5K ﹤0.01% 1457
2018
Q1 		$569K Sell
26,116
-675
-3% -$14.5K ﹤0.01% 1721
2017
Q4 		$541K Hold
26,791
– – ﹤0.01% 1795
2017
Q3 		$532K Hold
26,791
– – ﹤0.01% 1833
2017
Q2 		$463K Buy
26,791
+4,405
+20% +$56.9K ﹤0.01% 1882
2017
Q1 		$181K Hold
22,386
– – ﹤0.01% 2311
2016
Q4 		$176K Hold
22,386
– – ﹤0.01% 2334
2016
Q3 		$191 Hold
22,386
– – ﹤0.01% 2310
2016
Q2 		$261K Buy
+22,386
New +$280K ﹤0.01% 2109

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
QCM
Quantinno Capital Management New York $59.9B AUM 28.07% 1-Year Est. Return

VOYA Investment Management's NVCR Position: Q1 2026 in Review

VOYA Investment Management reduced its NovoCure (NVCR) stake by 2.4% in Q1 2026, selling an estimated $5.61K and leaving 18,165 shares worth $198K. The position accounts for ﹤0.01% of the portfolio, ranked #2119.

VOYA Investment Management first reported a position in NVCR in Q2 2016 and has held it in 40 quarters since. The position peaked at $67.8M in Q2 2021. 222 funds tracked by Wall St. Rank hold NVCR as of Q1 2026.

  • VOYA Investment Management held 18,165 shares of NovoCure worth $198K as of Q1 2026.
  • VOYA Investment Management sold 449 NovoCure shares in Q1 2026, an estimated $5.61K.
  • NovoCure made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #2119 holding.
  • VOYA Investment Management first reported a position in NovoCure in Q2 2016 and has held it in 40 quarters since.
  • VOYA Investment Management's NovoCure position peaked at $67.8M in Q2 2021.
  • 222 funds tracked by Wall St. Rank held NovoCure as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.